Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Expression and export of angiogenesis inhibitors as immunofusins

Expression and export of angiogenesis inhibitors as immunofusins

US Patent 8206718 · Granted Jun 26, 2012

Estimated economic value: $78,366,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-PD-L1 antibodies2025
Humanized and de-immunized antibodies2024
MrgX2 antagonists2024
Heterocyclic amides useful as protein modulators2024
Anti-PD-L1 and IL-2 cytokines2024
Light chain immunoglobulin fusion proteins and methods of use thereof2022
TIGIT antibodies, encoding nucleic acids and methods of using said antibodies in2022
Targeted TGFβ inhibition2022
Humanized antibodies2021
SIRP-α immunoglobulin fusion proteins2021
Heterocyclic amides useful as protein modulators2021
Anti-cancer antibodies with reduced complement fixation2020